Zeuzem, Stefan

Sorafenib in advanced hepatocellular carcinoma

Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine

Hepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and Studies

Cited by 13,097

High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double‐blind, randomized, placebo‐controlled trial†

Leuschner, U. F. H., Lindenthal, B., Herrmann, G., Arnold, J. C., Rössle, M., Cordes, H., Zeuzem, S., Hein, J., & Berg, T. (2010) · Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 317

Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon α and ribavirin therapy

Hofmann, W. P., Kronenberger, B., Bojunga, J., Stamm, B., Herrmann, E., Bücker, A., Mihm, U., Von Wagner, M., Zeuzem, S., & Sarrazin, C. (2008) · Journal of Viral Hepatitis

Hepatitis C virus researchBone health and osteoporosis research

Cited by 51